Guide for Authors
Regulatory Toxicology and Pharmacology, the Official Journal of the
International
Society for Regulatory Toxicology and Pharmacology, matches reports in toxicology, pharmacology, epidemiology, and allied
sciences, with reports on philosophical, legislative, legal, and public opinion issues that define public health, safety, and environmental
regulations. International in scope, the journal speaks at all levels of science and policy to the community of research and development
scientists, to business and legal decision makers, and to regulatory officials and legislative operators worldwide.
Types of paper
Ethical Treatment of Subjects.
Submission of a manuscript implies that the
authors warrant to have complied with institutional policies governing the ethical treatment of human subjects and animals, and that
the authors are ready to share the original approval documents if so requested.
Peer Review.
Submitted manuscripts
not rejected at first screen will undergo a peer review process that occasionally could require substantial revision and may last several
months, depending on the timeliness of author response.
Letters.
A brief one-printed-page observation may be published
under a "Letters" heading with the understanding that only one reply will be published in a rebuttal. A manuscript intended for publication
in Letters or a rebuttal should be so designated when submitted for publication.
Ethics in publishing
For information on Ethics in publishing and Ethical
guidelines for journal publication see
http://www.elsevier.com/publishingethics and
http://www.elsevier.com/ethicalguidelines.
Conflict of interest
All authors are requested to disclose any actual or potential conflict of interest
including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted
work that could inappropriately influence, or be perceived to influence, their work. See also
http://www.elsevier.com/conflictsofinterest.
Conflict of Interest Statement.
In compliance with the National Library of Medicine policy,
Regulatory Toxicology and Pharmacology requires full disclosure of all potential conflicts of interest. At the end of the manuscript
text (and in the cover letter of the manuscript), under a subheading "Conflict of Interest statement", all authors must disclose any
financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Affiliation
of authors submitting manuscripts in their role as members of industrial or government organizations may constitute sufficient disclosure.
Academic, nonprofit, consulting, advocacy, and all other authors are asked to disclose all sources of financial and material support
for the studies and manuscripts submitted. If there are no conflicts of interest, the authors should state, "The authors declare that
there are no conflicts of interest." Signed copies of the
Regulatory Toxicology and Pharmacology Conflict of Interest policy
form are required upon submission. The Conflict of Interest policy form can be downloaded
here
. In order to minimize delays, we strongly advise that the signed copies of these statements are prepared before you submit your
manuscript.
Submission declaration and verification
Submission of an article
implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture
or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and
tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published
elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder.
To verify originality, your article may be checked by the originality detection software iThenticate. See also
http://www.elsevier.com/editors/plagdetect.
Written
authorization by personal sources may be required at the Editor's discretion. Articles and any other material published in
Regulatory
Toxicology and Pharmacology represent the opinions of the authors, unless directly endorsed or authorized, should not be construed
to reflect the opinions of the International Society of Regulatory Toxicology and Pharmacology, the Editors, or the Publisher. Original
papers only will be considered.
Changes to authorship
This policy concerns
the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:
Before the accepted manuscript
is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal
Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed,
or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition,
removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must
follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2)
publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.
After the accepted manuscript
is published in an online issue: Any requests to add, delete, or rearrange author names in an article published in an online issue
will follow the same policies as noted above and result in a corrigendum.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this
and copyright see
http://www.elsevier.com/copyright). Acceptance of the agreement will ensure the widest possible dissemination
of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing
Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists
of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale
or distribution outside the institution and for all other derivative works, including compilations and translations (please consult
http://www.elsevier.com/permissions).
If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit
the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult
http://www.elsevier.com/permissions.
Retained author rights
As an author you (or your employer or institution) retain certain rights; for details
you are referred to:
http://www.elsevier.com/authorsrights.
Role of the
funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation
of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation
of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such
involvement then this should be stated. Please see
http://www.elsevier.com/funding.
Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors whose
articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions
of their grant awards. To learn more about existing agreements and policies please visit
http://www.elsevier.com/fundingbodies.
US National Institutes of Health (NIH) voluntary posting (" Public Access") policy.
Elsevier
facilitates author response to the NIH voluntary posting request (referred to as the NIH "Public Access Policy"; see
http://www.nih.gov/about/publicaccess/index.htm)
by posting the peer-reviewed author's manuscript directly to PubMed Central on request from the author, 12 months after formal publication.
Upon notification from Elsevier of acceptance, we will ask you to confirm via e-mail (by e-mailing us at
NIHauthorrequest@elsevier.com
) that your work has received NIH funding and that you intend to respond to the NIH policy request, along with your NIH award number
to facilitate processing. Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript
that will include peer-review comments, for posting 12 months after formal publication. This will ensure that you will have responded
fully to the NIH request policy. There will be no need for you to post your manuscript directly with PubMed Central, and any such posting
is prohibited.
Open access
This journal offers you the option of making
your article freely available to all via the ScienceDirect platform. To prevent any conflict of interest, you can only make this choice
after receiving notification that your article has been accepted for publication. The fee of $3,000 excludes taxes and other potential
author fees such as color charges. In some cases, institutions and funding bodies have entered into agreement with Elsevier to meet these
fees on behalf of their authors. Details of these agreements are available at
http://www.elsevier.com/fundingbodies. Authors
of accepted articles, who wish to take advantage of this option, should complete and submit the order form (available at
http://www.elsevier.com/locate/openaccessform.pdf).
Whatever access option you choose, you retain many rights as an author, including the right to post a revised personal version of your
article on your own website. More information can be found here:
http://www.elsevier.com/authorsrights.
Language and language services
Please write your text in good English (American or British usage is accepted,
but not a mixture of these). Authors who require information about language editing and copyediting services pre- and post-submission
please visit
http://webshop.elsevier.com/languageservices
or our customer support site at
http://support.elsevier.com
for more information.
Submission
Submission to this journal proceeds totally
online and you will be guided stepwise through the creation and uploading of your files. The system automatically converts source files
to a single PDF file of the article, which is used in the peer-review process. Please note that even though manuscript source files are
converted to PDF files at submission for the review process, these source files are needed for further processing after acceptance. All
correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail removing the need for
a paper trail.
Contact information:
Regulatory Toxicology and Pharmacology
Editorial Office
525 B Street, Suite 1900
San Diego, CA 92101-4495, USA
Telephone: (619) 699-6275
Fax: (619) 699-6211
E-mail:
rtp@elsevier.com
Referees
Please submit, with
the manuscript, the names, addresses and e-mail addresses of three potential referees. Note that the editor retains the sole right to
decide whether or not the suggested reviewers are used.
Use of wordprocessing software
It is important that the file be saved in the native format of the wordprocessor
used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed
and replaced on processing the article. In particular, do not use the wordprocessor's options to justify text or to hyphenate words.
However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, use only one
grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic
text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier:
http://www.elsevier.com/guidepublication).
Note that source files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also
the section on Electronic artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check'
functions of your wordprocessor.
Article Structure
Preparation
of Manuscript.
Authors of scientific reports should make a point to validate whether the data measure what they claim to
have measured or whether they could be distorted by adventitious interferences. Authors should also provide evidence that test and control
conditions differ only on account of the experimental variables tested, or are not affected by spurious confounding conditions. Conclusions
should focus on the most probable explanation of results, but should also endeavor to point out other less apparent but plausible conclusions.
Submissions that are not scientific experimental reports, such as policy positions and reviews, should strive for range, logical sequence,
clarity, and well-articulated conclusions.
The popularity of
Regulatory Toxicology and Pharmacology makes it necessary
to severely limit authors' discussions and data presentations in their manuscripts. Because the scope of environmental toxicology and
pharmacology is so great, it is not possible to devote many pages to a single issue.
Use generic names of chemicals whenever possible.
Proprietary names and trademarks should appear only to identify the source of the chemical, and subsequently only the generic name should
be used. All abbreviations, other than those for standard units, should be defined in text or in a footnote. Abbreviations should be
unpunctuated.
Manuscripts should be double-spaced throughout. Pages should be numbered consecutively and organized as follows:
The title page (p. 1) should contain the article title, authors' names and complete affiliations, footnotes to the title, and the address
for manuscript correspondence (including e-mail address and telephone and fax numbers). Separate word counts should be provided for abstract,
text, and references. A second page containing only the title of the paper should be submitted if the authors wish to obtain a blind
peer review.
The abstract (p. 2) must be a single paragraph that summarizes the main findings of the paper in less than 200 words.
After the abstract a list of up to 10 keywords that will be useful for indexing or searching should be included.
Format. Flexibility
of format is allowed, given the mix of multidisciplinary scientific reports and of policy and review articles of interest to the journal.
Clarity and brevity will be preferred.
Subdivision - numbered sections
Divide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, ...), 1.2,
etc. (the abstract is not included in section numbering). Use this numbering also for internal cross-referencing: do not just refer to
'the text'. Any subsection may be given a brief heading. Each heading should appear on its own separate line.
Introduction
State the objectives of the work and provide an adequate background, avoiding a detailed
literature survey or a summary of the results.
Material and methods
Provide
sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications
should be described.
Theory/calculation
A Theory section should extend,
not repeat, the background to the article already dealt with in the Introduction and lay the foundation for further work. In contrast,
a Calculation section represents a practical development from a theoretical basis.
Results
Results should be clear and concise.
Discussion
This should explore
the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive
citations and discussion of published literature.
Conclusions
The
main conclusions of the study may be presented in a short Conclusions section, which may stand alone or form a subsection of a Discussion
or Results and Discussion section.
Appendices
If there is more than
one appendix, they should be identified as A, B, etc. Formulae and equations in appendices should be given separate numbering: Eq. (A.1),
Eq. (A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc.
Essential title page information
•
Title.
Concise and informative. Titles are often
used in information-retrieval systems. Avoid abbreviations and formulae where possible.
•
Author names and affiliations.
Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses
(where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the
author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name
and, if available, the e-mail address of each author.
•
Corresponding author.
Clearly indicate who will handle
correspondence at all stages of refereeing and publication, also post-publication.
Ensure that telephone and fax numbers (with country
and area code) are provided in addition to the e-mail address and the complete postal address. Contact details must be kept up to date
by the corresponding author.
•
Present/permanent address.
If an author has moved since the work described
in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to
that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript
Arabic numerals are used for such footnotes.
Abstract
A concise and factual
abstract is required. The abstract should state briefly the purpose of the research, the principal results and major conclusions. An
abstract is often presented separately from the article, so it must be able to stand alone. For this reason, References should be avoided,
but if essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should be avoided, but if essential
they must be defined at their first mention in the abstract itself.
The
abstract should be fewer than 200 words.
Graphical abstract
A Graphical
abstract is optional and should summarize the contents of the article in a concise, pictorial form designed to capture the attention
of a wide readership online. Authors must provide images that clearly represent the work described in the article. Graphical abstracts
should be submitted as a separate file in the online submission system. Image size: Please provide an image with a minimum of 531 ×
1328 pixels (h × w) or proportionally more. The image should be readable at a size of 5 × 13 cm using a regular screen resolution
of 96 dpi. Preferred file types: TIFF, EPS, PDF or MS Office files. See
http://www.elsevier.com/graphicalabstracts for examples.
Authors can make use of Elsevier's Illustration and Enhancement service to ensure the best presentation of their images also in accordance
with all technical requirements:
Illustration
Service.
Highlights
Highlights are mandatory for this journal.
They consist of a short collection of bullet points that convey the core findings of the article and should be submitted in a separate
file in the online submission system. Please use 'Highlights' in the file name and include 3 to 5 bullet points (maximum 85 characters,
including spaces, or, maximum 20 words per bullet point). See
http://www.elsevier.com/highlights for examples.
Keywords
Provide up to 10 keywords.
Abbreviations
Define abbreviations that are not standard in this field in a footnote to be placed on the first page of the article. Such abbreviations
that are unavoidable in the abstract must be defined at their first mention there, as well as in the footnote. Ensure consistency of
abbreviations throughout the article.
Acknowledgements
Collate acknowledgements
in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote
to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing
assistance or proof reading the article, etc.).
Database linking and Accession numbers
Elsevier aims at connecting online articles with external databases which are useful in their respective research communities.
If your article contains relevant unique identifiers or accession numbers (bioinformatics) linking to information on entities (genes,
proteins, diseases, etc.) or structures deposited in public databases, then please indicate those entities according to the standard
explained below.
Authors should explicitly mention the
database abbreviation (as mentioned below) together with the actual database
number, bearing in mind that an error in a letter or number can result in a dead link in the online version of the article.
Please
use the following format:
Database ID: xxxx
Links can be provided in your online article to the following databases (examples
of citations are given in parentheses):
•
GenBank: Genetic
sequence database at the National Center for Biotechnical Information (NCBI) (GenBank ID: BA123456)
•
PDB:
Worldwide Protein Data Bank (PDB ID: 1TUP)
•
CCDC: Cambridge Crystallographic
Data Centre (CCDC ID: AI631510)
•
TAIR: The Arabidopsis Information
Resource database (TAIR ID: AT1G01020)
•
NCT: ClinicalTrials.gov
(NCT ID: NCT00222573)
•
OMIM: Online Mendelian Inheritance
in Man (OMIM ID: 601240)
•
MINT: Molecular INTeractions
database (MINT ID: 6166710)
•
MI: EMBL-EBI OLS Molecular
Interaction Ontology (MI ID: 0218)
•
UniProt: Universal Protein Resource
Knowledgebase (UniProt ID: Q9H0H5)
Footnotes
Footnotes should be used
sparingly. Number them consecutively throughout the article, using superscript Arabic numbers. Many wordprocessors build footnotes into
the text, and this feature may be used. Should this not be the case, indicate the position of footnotes in the text and present the footnotes
themselves separately at the end of the article. Do not include footnotes in the Reference list.
Table footnotes
Indicate
each footnote in a table with a superscript lowercase letter.
Artwork
Electronic artwork
General points
• Make sure you use uniform lettering and sizing
of your original artwork.
• Save text in illustrations as 'graphics' or enclose the font.
• Only use the following
fonts in your illustrations: Arial, Courier, Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
•
Produce images near to the desired size of the printed version.
• Submit each figure as a separate file.
A detailed guide
on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged
to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless of the application
used, when your electronic artwork is finalised, please 'save as' or convert the images to one of the following formats (note the resolution
requirements for line drawings, halftones, and line/halftone combinations given below):
EPS: Vector drawings. Embed the font or save
the text as 'graphics'.
TIFF: Color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line
drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is'.
Please
do not:
• Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too low;
•
Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Color artwork
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office
files) and with the correct resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure,
at no additional charge, that these figures will appear in color on the Web (e.g., ScienceDirect and other sites) regardless of whether
or not these illustrations are reproduced in color in the printed version.
For color reproduction in print, you will receive information
regarding the costs from Elsevier after receipt of your accepted article. Please indicate your preference for color: in print or
on the Web only. For further information on the preparation of electronic artwork, please see
http://www.elsevier.com/artworkinstructions.
Please note: Because of technical complications which can arise by converting color figures to 'gray scale' (for the printed version
should you not opt for color in print) please submit in addition usable black and white versions of all the color illustrations.
Figure captions
Ensure that each illustration has a caption. Supply captions separately, not attached
to the figure. A caption should comprise a brief title (
not on the figure itself) and a description of the illustration. Keep
text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Tables
Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables below the
table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables and ensure that
the data presented in tables do not duplicate results described elsewhere in the article.
References
References should be cited in the text by the first author's surname followed by et al. If only two authors
are listed, both names should be cited. References should be listed alphabetically by name. Journal names should follow the style of
the latest edition of the Chemical Abstracts Service Source Index. Only articles that have been published or are in press should be included
in the references. Unpublished results or personal communications should be cited as such in the text.
Gerrity, T.R., Henry, C.J.,
1990. Principles of Route-to-Route Extrapolation for Risk Assessment. Elsevier, New York.
LaPuma, P.T., Brain S. Rhodes, B.S., 2002.
Chromate content versus particle size for aircraft paints. Regul. Toxicol. Pharmacol. 36, 318-324.
Mettam, O.R., Adams, L.B., 1999.
How to prepare an electronic version of your article, in: Jones, B.B., Smith, R.Z. (Eds.), Introduction to the Electronic Age. E-Publishing
Inc., New York, pp. 281-304.
Citation in text
Please ensure that
every reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be
given in full. Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the
text. If these references are included in the reference list they should follow the standard reference style of the journal and should
include a substitution of the publication date with either 'Unpublished results' or 'Personal communication'. Citation of a reference
as 'in press' implies that the item has been accepted for publication.
Web references
As a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI,
author names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after
the reference list) under a different heading if desired, or can be included in the reference list.
References in a special issue
Please ensure that the words 'this issue' are added to any references
in the list (and any citations in the text) to other articles in the same Special Issue.
Reference management software
This journal has standard templates available in key reference management packages
EndNote (
http://www.endnote.com/support/enstyles.asp) and Reference Manager (
http://refman.com/support/rmstyles.asp).
Using plug-ins to wordprocessing packages, authors only need to select the appropriate journal template when preparing their article
and the list of references and citations to these will be formatted according to the journal style which is described below.
Reference style
Text: All citations in the text should refer to:
1.
Single author:
the author's name (without initials, unless there is ambiguity) and the year of publication;
2.
Two authors: both authors'
names and the year of publication;
3.
Three or more authors: first author's name followed by 'et al.' and the year of publication.
Citations may be made directly (or parenthetically). Groups of references should be listed first alphabetically, then chronologically.
Examples: 'as demonstrated (Allan, 2000a, 2000b, 1999; Allan and Jones, 1999). Kramer et al. (2010) have recently shown ....'
List:
References should be arranged first alphabetically and then further sorted chronologically if necessary. More than one reference from
the same author(s) in the same year must be identified by the letters 'a', 'b', 'c', etc., placed after the year of publication.
Examples:
Reference to a journal publication:
Van der Geer, J., Hanraads, J.A.J., Lupton, R.A., 2010. The art of writing a scientific article.
J. Sci. Commun. 163, 51–59.
Reference to a book:
Strunk Jr., W., White, E.B., 2000. The Elements of Style, fourth ed. Longman,
New York.
Reference to a chapter in an edited book:
Mettam, G.R., Adams, L.B., 2009. How to prepare an electronic version of
your article, in: Jones, B.S., Smith , R.Z. (Eds.), Introduction to the Electronic Age. E-Publishing Inc., New York, pp. 281–304.
Journal abbreviations source
Journal names should be abbreviated according to
Index Medicus journal
abbreviations:
http://www.nlm.nih.gov/tsd/serials/lji.html;
List of title word abbreviations:
http://www.issn.org/2-22661-LTWA-online.php;
CAS (Chemical Abstracts Service):
http://www.cas.org/sent.html.
Video
data
Elsevier accepts video material and animation sequences to support and enhance your scientific research. Authors who
have video or animation files that they wish to submit with their article are strongly encouraged to include these within the body of
the article. This can be done in the same way as a figure or table by referring to the video or animation content and noting in the body
text where it should be placed. All submitted files should be properly labeled so that they directly relate to the video file's content.
In order to ensure that your video or animation material is directly usable, please provide the files in one of our recommended file
formats with a preferred maximum size of 50 MB. Video and animation files supplied will be published online in the electronic version
of your article in Elsevier Web products, including ScienceDirect:
http://www.sciencedirect.com. Please supply 'stills'
with your files: you can choose any frame from the video or animation or make a separate image. These will be used instead of standard
icons and will personalize the link to your video data. For more detailed instructions please visit our video instruction pages at
http://www.elsevier.com/artworkinstructions.
Note: since video and animation cannot be embedded in the print version of the journal, please provide text for both the electronic and
the print version for the portions of the article that refer to this content.
Supplementary
data
Elsevier accepts electronic supplementary material to support and enhance your scientific research. Supplementary files
offer the author additional possibilities to publish supporting applications, high-resolution images, background datasets, sound clips
and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier Web products,
including ScienceDirect:
http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable,
please provide the data in one of our recommended file formats. Authors should submit the material in electronic format together with
the article and supply a concise and descriptive caption for each file. For more detailed instructions please visit our artwork instruction
pages at
http://www.elsevier.com/artworkinstructions.
Submission checklist
The following list will be useful during the final checking of an article prior to sending it to the journal for review. Please
consult this Guide for Authors for further details of any item.
Ensure that the following items are present:
One author
has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
•
Telephone and fax numbers
All necessary files have been uploaded, and contain:
• Keywords
• All figure captions
• All tables (including title, description, footnotes)
Further considerations
• Manuscript has been 'spell-checked'
and 'grammar-checked'
• References are in the correct format for this journal
• All references mentioned in the Reference
list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources
(including the Web)
• Color figures are clearly marked as being intended for color reproduction on the Web (free of charge)
and in print, or to be reproduced in color on the Web (free of charge) and in black-and-white in print
• If only color on the
Web is required, black-and-white versions of the figures are also supplied for printing purposes
For any further information please
visit our customer support site at
http://support.elsevier.com.
Use of
the Digital Object Identifier
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The
DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic
publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press'
because they have not yet received their full bibliographic information. The correct format for citing a DOI is shown as follows (example
taken from a document in the journal
Physics Letters B):
doi:10.1016/j.physletb.2010.09.059
When you use the DOI to
create URL hyperlinks to documents on the web, the DOIs are guaranteed never to change.
Proofs
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do not have an
e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download the files
themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need to download Adobe Reader version
7 (or higher) available free from
http://get.adobe.com/reader. Instructions on how to annotate PDF files will accompany
the proofs (also given online). The exact system requirements are given at the Adobe site:
http://www.adobe.com/products/reader/tech-specs.html.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return
them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark
the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the
pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text,
tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission
from the Editor. We will do everything possible to get your article published quickly and accurately – please let us have all your
corrections within 48 hours. It is important to ensure that all corrections are sent back to us in one communication: please check carefully
before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that
Elsevier may proceed with the publication of your article if no response is received.
Offprints
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail. For an extra
charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. The PDF
file is a watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining
the terms and conditions of use.
For inquiries relating
to the submission of articles (including electronic submission) please visit this journal's homepage. Contact details for questions arising
after acceptance of an article, especially those relating to proofs, will be provided by the publisher. You can track accepted articles
at
http://www.elsevier.com/trackarticle. You can also check our Author FAQs (
http://www.elsevier.com/authorFAQ)
and/or contact Customer Support via
http://support.elsevier.com.
